A61P 27/10
For accommodation disorders
Official title: for accommodation disorders, e.g. myopia
A61P27/10 (For accommodation disorders) appears on 443 US grants and 758 published applications in this corpus.
Search patents in A61P- Granted patents
- 443
- Published applications
- 758
- Assignees
- 287
- Inventors
- 1,120
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 7 | 10 |
| 2003 | 6 | 16 |
| 2004 | 6 | 17 |
| 2005 | 5 | 16 |
| 2006 | 8 | 16 |
| 2007 | 2 | 16 |
| 2008 | 6 | 33 |
| 2009 | 9 | 36 |
| 2010 | 19 | 26 |
| 2011 | 19 | 38 |
| 2012 | 33 | 38 |
| 2013 | 23 | 34 |
| 2014 | 32 | 37 |
| 2015 | 31 | 36 |
| 2016 | 17 | 35 |
| 2017 | 20 | 27 |
| 2018 | 19 | 32 |
| 2019 | 26 | 37 |
| 2020 | 31 | 44 |
| 2021 | 25 | 37 |
| 2022 | 15 | 39 |
| 2023 | 16 | 39 |
| 2024 | 16 | 47 |
| 2025 | 20 | 25 |
| 2026 | 15 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Agent for treating myopia, preventing myopia and/or suppressing myopia progression25 Aug 2026US 12,714,715 B2Boehringer Ingelheim International GmbH
- Eye drops with citric acid as the sole active ingredient11 Aug 2026US 12,702,653 B2
- Method for improving visual acuity11 Aug 2026US 12,702,683 B2Mesoblast International Sarl
- Treating refractive disorders by targeting peroxisome proliferator-activated receptor (PPAR) signaling pathway28 Jul 2026US 12,691,106 B2Centre for Eye and Vision Research Limited
- Compositions and methods for the treatment of presbyopia16 Jun 2026US 12,653,779 B2Lenz Therapeutics Operations, Inc.
- Nucleic acid construct that encodes chimeric rhodopsin24 Sep 2026US 2026/0285934 A1Restore Vision Inc.
- Methods and compositions for treatment of mydriasis10 Sep 2026US 2026/0263422 A1Opus Genetics, Inc.
- Treatment of Myopic Progression27 Aug 2026US 2026/0248846 A1University of Utah Research Foundation
- Method and composition for preventing or treating myopia20 Aug 2026US 2026/0240925 A1Tsubota Laboratory, Inc.
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations13 Aug 2026US 2026/0232704 A1Arbormentis LLC
Most cited
By later US patents
- Antibody compositions for selectively inhibiting VEGF356US 6,342,219 B12002
- Methods and compositions for inhibition of angiogenesis231US 5,712,291 AChildren's Medical Center Corporation · 1998
- Methods and compositions for inhibition of angiogenesis185US 5,629,327 AChildren's Hospital Medical Center · 1997
- Antibody conjugate compositions for selectively inhibiting VEGF181US 6,342,221 B12002
- Methods and compositions for inhibition of angiogenesis152US 5,593,990 AChildren's Medical Center Corporation · 1997